The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Primary tumor glioblastoma is the most common malignant brain. Standard treatment includes
biopsy or excision of the tumor in order to obtain a pathological diagnosis, and tumor mass
reduction. After the surgery patients are treated with radiation and Temodal. The most common
psychiatric symptom in this patient population is depression, valued at up to approximately
50% in patients with glioma . Depression not only adversely affects the quality of life of
patients but also impairs the ability and cognitive function due to the complex clinical
course of patients with glioblastoma. There is a tendency to give Diagnosis of depression in
this patient population, due to a lack of awareness, knowledge and literature on the subject.
This study was designed to prospectively randomized, controlled, double-blind study.
This method of recruitment - patients who undergo resection or biopsy of glioblastoma (newly
diagnosed glioblastoma), immediately after diagnosis, patients will receive an explanation
about the study and sign a consent form will enter research.